Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px

Person › Details

Matthew E. Gugino (Danaher Corporation (NYSE: DHR))

Gugino, Matthew E. (Danaher 201407 VP Investor Relations)

	Organisation	Danaher Corporation (NYSE: DHR)
	Group	Danaher (Group)
	Product	analytical instrument
	Product 2	diagnostics (medical/biological)

Record changed: 2022-11-24

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for Matthew E. Gugino

[1] Danaher Corporation. (3/31/20). "Press Release: Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences, Business Will Be Called Cytiva". Washington, DC....
[2] Danaher Corporation. (2/25/19). "Press Release: Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion". Washington, DC....
[3] Danaher Corporation. (1/2/19). "Press Release: Danaher to Present at J.P. Morgan Healthcare Conference". Washington, DC....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top